NCT00431431View on ClinicalTrials.gov

Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090)

PHASE4CompletedINTERVENTIONAL
Enrollment

324

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

February 15, 2005

Study Completion Date

February 15, 2005

Conditions
Osteopenia
Interventions
DRUG

tibolone

2 years treatment with tibolone (1.25 mg Org OD-14)

DRUG

raloxifen

2 years treatment with raloxifene (60 mg)

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00431431 - Comparison of Tibolone and Raloxifene on Bone Mineral Density in Osteopenic Postmenopausal Women (P06090) | Biotech Hunter | Biotech Hunter